BlackB
2021-11-04

$Cassava Sciences Inc(SAVA)$Review by Journal of Neuroscience Shows No Evidence of Data Manipulation in Technical Paper Foundational to Cassava Sciences’ Lead Drug Candidate

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

  • ElsieDewey
    2021-11-05
    ElsieDewey
    This may be a positive at the company level. For the biomedical industry, quality assurance is too important. Fortunately, it passed the test.
  • MurrayBulwer
    2021-11-05
    MurrayBulwer
    This may be good news for Sava. Paper fraud or technology fraud has too much impact on a company.
发表看法
2